Atreca, Inc. financial data

Industry
Pharmaceutical Preparations
Location
835 Industrial Road,, Suite 400, San Carlos, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 353 % -54.5%
Debt-to-equity 121 % +124%
Return On Equity -201 % -140%
Return On Assets -90.8 % -67.3%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 48.8M USD -75.4%
Weighted Average Number of Shares Outstanding, Basic 39.4M shares +1.64%
Weighted Average Number of Shares Outstanding, Diluted 39.4M shares +1.64%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 50.5M USD -32.9%
General and Administrative Expense 27.8M USD -10.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -97.8M USD +7.19%
Net Income (Loss) Attributable to Parent -97.8M USD +7.19%
Earnings Per Share, Basic -2.5 USD/shares +9.42%
Earnings Per Share, Diluted -2.5 USD/shares +9.42%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.5M USD -35.6%
Assets, Current 24.7M USD -73.4%
Property, Plant and Equipment, Net 1.61M USD -95.9%
Operating Lease, Right-of-Use Asset 35.2M USD -4.68%
Assets 26.3M USD -84.7%
Accounts Payable, Current 4.06M USD +139%
Employee-related Liabilities, Current 154K USD -95.2%
Accrued Liabilities, Current 9.29M USD -1.14%
Liabilities, Current 15.6M USD +6.95%
Operating Lease, Liability, Noncurrent 58.4M USD -6.07%
Liabilities 15.6M USD -79.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4K USD +99.3%
Retained Earnings (Accumulated Deficit) -533M USD -22.4%
Stockholders' Equity Attributable to Parent 10.8M USD -88.8%
Liabilities and Equity 26.3M USD -84.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD +43.5%
Net Cash Provided by (Used in) Financing Activities 109K USD -97.1%
Net Cash Provided by (Used in) Investing Activities 23M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.6M USD -33.8%
Deferred Tax Assets, Valuation Allowance 103M USD +17.3%
Deferred Tax Assets, Gross 114M USD +30%
Operating Lease, Liability 1.28M USD -98%
Payments to Acquire Property, Plant, and Equipment 80K USD +17.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.2M USD +8.24%
Lessee, Operating Lease, Liability, to be Paid 1.28M USD -98.6%
Property, Plant and Equipment, Gross 7.63M USD -86.2%
Operating Lease, Liability, Current 1.28M USD -62.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.06M USD +2.78%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.85M USD +2.76%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -105%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.2M USD -15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.29M USD +2.78%
Deferred Tax Assets, Operating Loss Carryforwards 69.3M USD +8.99%
Unrecognized Tax Benefits 4.74M USD -4.26%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.52M USD +2.79%
Operating Lease, Payments 5.1M USD +168%
Additional Paid in Capital 544M USD +2.2%
Depreciation, Depletion and Amortization 1.29M USD -4.59%
Share-based Payment Arrangement, Expense 11.6M USD -37.3%